Search
Grepafloxacin
go.drugbank.com/drugs/DB00365ApprovedWithdrawnDue to the QTc-prolonging potential, as indicated by the changes in the QT interval on the electrocardiogram, and the risk for cardiovascular adverse events, grepafloxacin was withdrawn in the United States … Grepafloxacin is an oral broad-spectrum quinoline antibacterial agent used to treat bacterial infections.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InhibitorsDental Caries Extending Into Dentine
go.drugbank.com/conditions/DBCOND0061100Synonyms: Dental caries confined to enamel and dentineSeborrheic Dermatitis
go.drugbank.com/conditions/DBCOND0036095Synonyms: Greasy skin due to excessive secretion of sebum (disorder)Substance Addiction
go.drugbank.com/conditions/DBCOND0033529Drugs: ValpromideSynonyms: Addiction to drugsGanaxolone
go.drugbank.com/drugs/DB05087ApprovedInvestigational[A3197] Ganaxolone belongs to a class of compounds referred to as neurosteroids. … [A3197] Endogenous neurosteroids, which comprise certain metabolites of progesterone and deoxycorticosterone, bind potently and specifically to GABA<sub>A</sub> receptors to enhance their inhibitory effects
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 SubstratesLinoleic acid
go.drugbank.com/drugs/DB14104ApprovedMixtures: SIMILAC ALIMENTUM 400 G TOZ, Gla 130 Primrose OilMK-0777
go.drugbank.com/drugs/DB12238InvestigationalMK-0777 has been used in trials studying the treatment of Schizophrenia, Anxiety Disorder, and Generalized Anxiety Disorder.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesMK-886
go.drugbank.com/drugs/DB16739ExperimentalMK-886 is an experimental inhibitor of leukotriene synthesis.
MK-4965
go.drugbank.com/drugs/DB08460ExperimentalMK-4965 is an HIV-1 reverse transcriptase inhibitor.
Estradiol benzoate
go.drugbank.com/drugs/DB13953ApprovedVet approvedWithdrawn[DB00783] is commonly produced with an ester side-chain as endogenous estradiol has very low oral bioavailability on its own (2-10%). … First-pass metabolism by the gut and the liver quickly degrades the estradiol molecule before it gets a chance to enter systemic circulation and exert its estrogenic effects [A12102].
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A1 Substrates